Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis

Surgical Neurology International

Volumn 4, Issue 1, 2013, Pages

  Blaylock, Russell L ^a  

^a Belhaven College   (United States)

Author keywords

Glioblastoma; immunoexcitotoxicity; inflammatory cytokines; metastasis; tumor invasion

Indexed keywords

AMPA RECEPTOR; CALCIUM ION; CURCUMIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; QUERCETIN; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA;

ASTROCYTOMA; CALCIUM CELL LEVEL; CANCER GROWTH; CANCER INVASION; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CHRONIC INFLAMMATION; CYTOKINE RELEASE; EXCITOTOXICITY; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HUMAN; HYPOXIA; IMMUNOEXCITOTOXICITY; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; ULCERATIVE COLITIS;

EID: 84875181212     PISSN: None     EISSN: 21527806     Source Type: Journal    
DOI: 10.4103/2152-7806.106577     Document Type: Review

References (130)

1. Abou-Ghazal M, Yang DS, Qiao W, Reina-Ortiz C, Wei J, Kong LY, et al. The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. Clin Cancer Res 2008;14:8228-35.
2. Acarin L, Peluffo H, Gonsalez B, Castellano B. Expression of inducible nitric oxide synthase and cyclooxygenase-2 after excitotoxic damage to the immature rat brain. J Neurosci Res 2002;68:745-54.
3. Aggarwal BB. Nuclear factor-kappaB: The enemy within. Cancer Cell 2004;6:203-8.
4. Ali IU, Schriml LM, Dean M. Mutational spectra of PTEN/MMAC1 gene: A tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 1999;91:1922-32.
5. Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: Role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 2007;72:29-39.
6. Bacus SS, Altomare DA, Lyass L, Chin DM, Farrell MP, Gurova K, et al. Akt2 is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival. Oncogene 2002;21:3532-40.
7. Bao S, Wu Q, Mclendon RE, Hao Y, Shi Q, Hielmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-60.
8. Beattie EC, Stellwagen D, Mortishita W, Bresnahan JC, Ha BK, Von Zastrow M, et al. Control of synaptic strength by glial TNFalpha. Science 2002;295:2282-85.
9. Bernadino L, Xapelli S, Silva AP, Jakobsen B, Poulsen FR, Oliverira CR, et al. Modular effects of interleukin-1beta and tumor necrosis factor-Alpha on AMPA-induced excitotoxicity in mouse organotypic slice cultures. J Neurosci 2005;25:6734-44.
10. Bian XW, Yang SX, Chen JH, Ping YF, Zhou XD, Wang QL, et al. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival. Neurosurgery 2007;61:570-8.
11. Biber K, Neumann H, Inuoue K, Boddeke HW. Neurons 'On' and 'Off' signals control microglia. Trends Neurosci 2007;30:569-602.
12. Blaylock R, Maroon J. Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis. Surg Neurol Int 2011;2:107.
13. Bochme SA, Lio FM, Maciejewski-Lenoir D, Bacon KB, Conlon PJ. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol 2000;165:397-403.
14. Bogaert E, d'Ydewalle C, Van Den Bosch L. Amyotrophic lateral sclerosis and excitotoxicity: From pathological mechanism to therapeutic target. CNS Neurol Disord Drug Targets 2010;9:297-304.
15. Brocke KS, Stufner C, Luksch H, Geiger KD, Stepulak A, Marzahn J, et al. Glutamate receptors in pediatric tumors of the central nervous system. Cancer Biol Ther 2010;9:455-68.
16. Chang CY, Li MC, Liao SL, Huang YL, Shen CC, Pan HC. Prognostic and clinical implications of IL-6 expression in glioblastoma multiforme. J Clin Neurosci 2005;12:930-3.
17. Chang HJ, Yoo BC, Lim SB, Jeong SY, Kim WH, Park JG. Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin Cancer Res 2005;11:3288-95.
18. Chao CC, Hu S. Tumor necrosis factor-Alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev Neurosci 1994;16:172-9.
19. Chaparro-Huerta V, Rivera-Cervantes MC, Flores-Soto ME, Gomez-Pinedo U, Beas-Zarate C. Proinflammatory cytokines and apoptsis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats. J Neuroimmunol 2005;165:53-62.
20. Choi BH, Kim CG, Lim Y, Shin SY, Lee YH. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF Kappa B pathway. Cancer Lett 2008;259:111-8.
21. Choi KY, Chang K, Pickel JM, Badger JD 2nd, Roche KW. Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice. Proc Natl Acad Sci USA 2011;108:15219-24.
22. Chung WJ, Lyons SA, Nelson GM, Hamza H, Gladson CL, Gillespie GY, et al. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci 2005;25:7101-10.
23. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 1995;55:727-30.
24. Cobbs CS, Samanta M, Harkins LE, Gillespie GY, Merrick BA, MacMillan-Crow LA. Evidence for peroxinitrite-mediated modifications to p53 in human gliomas: Possible functional consequences. Arch Biochem Biophys 2001;394:167-72.
25. Collet G, Skrzypek K, Grillion C, Matejuk A, El Hafni-Rahbi B, Lamerant-Favel N, et al. Hypoxia control to normalize pathologic angiogenesis: Potential role for endothelial precursor cells and miRNAs regulation. Vascul Pharmacol 2012;56:252-61.
26. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 2009;30:1073-81.
27. Cortesio CL, Chan KT, Perrin BJ, Burton NO, Zhang S, Zhang ZY, et al. Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion. J Cell Biol 2008;180:957-71.
28. Coussens LM, Werb Z Inflammation and cancer. Nature 2002;420:860-7.
29. Coussens LM, Werb Z Inflammatory cells and cancer: Think different! J Exp Med 2001;193:F23-6.
30. de Groot JF, Piao Y, Lu L, Fuller GN, Yung WK. Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation. J Neurooncol 2008;88:121-33.
31. Deng W, Rosenberg PA, Volpe JJ, Jensen FE. Calcium-permeable AMPA/kainite receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc Natl Acad Sci USA 2003;100:6801-6.
32. Dimov I, Tasic-Dimov D, Conic I, Stefanovic V. Glioblastoma multiforme stem cells. Scientific World Journal 2011;11:930-58.
33. Ehtesham M, Mapara KY, Stevenson CB, Thompson RC. CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett 2009;274:305-12.
34. Eiro N, Vizoso FJ Inflammation and cancer. World Gastrointest Surg 2012;4:62-72.
35. Emdad L, Sarkar D, Su ZZ, Randolph A, Boukerche H, Valerie K, et al. Activation of the nuclear factor kappaB pathway by astrocyte gene-1: Implications for tumor progression and metastasis. Cancer Res 2006;66:1509-16.
36. Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, et al. Chemotheray resistance of glioblastoma stem cells. Cell Death Differ 2006;13:1238-41.
37. Fathallah-Shaykh HM, Gao W, Cho M, Herrera MA. Priming in the brain, an immunologically privileged organ, elicits anti-tumor immunity. In J Cancer 1998;75:266-76.
38. Ferguson AR, Christensen RN, Gensel JC, Miller BA, Sun F, Beattie EC, et al. Cell death after spinal cord injury is exacerbated by rapid TNF-Alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J Neurosci 2008;28:11391-400.
39. Ghods AJ, Irvin D, Liu G, Yuan X, Abdulkadir IR, Tunici B, et al. Spheres isolated from 9 L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 2007;25:1645-53.
40. Giannone G, Ronde P, Gaire M, Haiech J, Takeda K. Calcium oscillations trigger focal adhesion disassembly in human U87 astrocytoma cells. J Biol Chem 2002;277:26364-71.
41. Gout PW, Buckley AR, Simms CR, Bruchovsky N. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition if the x(c)-cystine transporter: A new action for an old drug. Leukemia 2001;15:1633-40.
42. Graham V, Khudyakov J, Ellis P, Pevny L. SOX2 functions to maintain neural progenitor identity. Neuron 2003;39:749-65.
43. Grassi F, Miles AM, Monaco L, Puntuieri A, Santoni A, Eusebi F. TNF-Alpha increases the frequency of spontaneous miniature synaptic currents in cultured rat hippocampal neurons. Brain Res 1994;65:226-30.
44. Grivennikov SI, Karin M. Dangerous liasions: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 2010;21:11-9.
45. Gupta SC, Kim JH, Prasad S, Aggarwal BB. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 2010;29:405-34.
46. Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G, Stokoe D. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol 1998;8:1195-8.
47. Haas HS, Linecker A, Pfragner R, Sadjak A. Peripheral glutamate signaling in head and neck areas. Head Neck 2010;32:1554-72.
48. Hara A, Okayasu I. Cycloogenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: Correlation with angiogenesis and prognostic significance. Acta Neuropathol 2004;108:43-8.
49. Hendriks JJ, Teunissen CE, de Varies HE, Dijkstra CD. Macrophages and neurodegeneration. Brain Res Brain Res Rev 2005;48:185-95.
50. Holladay FP, Choudhuri R, Heitz T, Wood GW. Generation of cytotoxic immune responses during the progression of a rat glioma. J Neurosurg 1994;80:90-6.
51. Hussain SF, Yang D, Suki D, Aldape K, Grimm E, Heimberger AB. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol 2006;8:261-79.
52. Hutzen B, Friedman L, Sobo M, Likn L, Cen L, De Angelis S, et al. Curcumin analogue GO-YO30 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomas. In J Oncol 2009;35:867-72.
53. Ischiuchi S, Yoshida Y, Sugawara K, Aihara M, Ohtani T, Watanabe T, et al. Ca 2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation. J Neurosci 2007;27:7987-8001.
54. Ischiuchi S, Tsuzuki K, Yoshida N, Hagimura N, Okado H, Miwa A, et al. Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 2002;8:971-8.
55. Jang HS, Lai S, Greenwood JA. Calpain 2 is required for glioblastoma cell invasion: Regulation of matrix metalloproteinase 2. Neurochem Res 2010;35:1796-804.
56. Kaltschmidt C, Kaltschmidt B, Bacuerle PA. Stimulation of inotropic glutamate receptors activates transcription factor NF-κB in primary neurons. Proc Nat Acad Sci USA 1995;92:9618-22.
57. Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ, Fisher PB. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 2005;353:8-15.
58. Kato T, Sawamura Y, Tada M, Sakuma S, Sudo M, Abe H. P55 and p75 tumor necrosis factor receptor expression in human glioblastoma cells. Neural Med Chir (Tokyo) 1995;35:567-74.
59. Kaur M, Agarwal R. Silymarin and epithelial cancer chemoprevention: How close are we to bedside? Toxicol Appl Pharmacol 2007;224:350-9.
60. Kim R, Emi M, Tanabe K. Cancer immunosuppression and autoimmune disease: Beyond immunosuppressive networks for tumor immunity. Immunology 2006;119:254-64.
61. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: From concept to clinical diagnosis. Neuro-Oncolol 1999;1:44-51.
62. Kleihues P, Ohgaki H. Phenotype vs genotype in the evolution of astrocytic brain tumors. Toxicol Pathol 2000;28:164-70.
63. Kumuro H, Rakic P. Intracellular Ca2+ fluctuations modulate the rate of neuronal migration. Neuron 1996;17:275-85.
64. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008;269:199-225.
65. Kwon CH, Zhao D, Chen J, Alcantara S, Li Y, Burns DK, et al. Pten haploinsufficency accelerates formation of high-grade astrocytomas. Cancer Res 2008;68:3286-94.
66. Lang R. Tuning of macrophage responses by Stat3-inducing cytokines: Molecular mechanisms and consequences in infection. Immunobiology 2005;210:63-76.
67. Leonoudakis D, Zhao P, Beattie EC. Rapid tumor necrosis factor alpha-induced exocytosis of glutamate receptor 2-lacking AMPA receptors to extrasynaptic plasma membrane potentiates excitotoxicity. J Neurosci 2008;28:2119-30.
68. Liang HP, Brophy TM, Hogg PJ. Redox properties of the tissue factor Cys186-Cys209 disulfide bond. Biochem J 2011;437:455-60.
69. Li J, Yen C, Liaw D, Podsypania K, Bose S, Wamg SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-7.
70. Li M, Zhang Z, Hill DL, Wang H, Zhang R. Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects through the PI3K/mTOR/ETS2 pathway. Cancer Res 2007;67:1988-96.
71. Limtrakul P. Curcumin as a chemosensitizer. Adv Exp Med Biol 2007;595:269-300.
72. Lin CY, Lynch G, Gall CM. AMPA receptor stimulation increases alpha5beta1 integrin surface expression, adhesive function and signaling. J Neurochem 2005;94:531-46.
73. Lin JK. Molecular targets of curcumin. Adv Exp Med Biol 2007;595:227-43.
74. Lino MM, Merio A. PI3Kinase signaling in glioblastoma. J Neurooncol 2011;103:417-27.
75. Liu B, Liao M, Mielke JG, Ning K, Chen Y, Li L, et al. Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. J Neurosci 2006;26:5309-19.
76. Liu GJ, Nagarajah R, Banati RB, Bennett MR. Glutamate induces directed chemotaxis of microglia. Eur J Neurosci 2009;29:1108-18.
77. Lubin FD, Jhonston LD, Sweatt JD, Anderson AE. Kainate mediates nuclear factor-kappa B activation in hippocampus via phosphatidylinositol-3 kinase and extracellular signal-regulates kinase. Neuroscience 2005;133:969-81.
78. Luksch H, Uckermann O, Stepulak A, Hendruschk S, Marzahn J, Bastain S, et al. Silencing of selected glutamate receptor subunits modulates cancer growth. Anticancer Res 2011;313:181-92.
79. Lyons SA, Chung WJ, Weaver AK, Ogunrinu T, Sontheiner H. Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res 2007;67:9463-71.
80. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, et al. Malignant glioma: Genetics and biology of a grave matter. Gene Dev 2001;15:1311-33.
81. Malone A. Enteral formula selection: A product Review of Selected Product Catagories. Pract Gastroenterol 2006;44-74.
82. Misra N, Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Cutting edge: Human CD4+CD25+Tcells restrain the maturation and antigen-presenting function of dendritric cells. J Immunol 2004;172:4676-80.
83. Mobasheri A, Richardson S, Mobasheri R, Sakibael M, Hoyland JA. Hypoxia inducible factor-1 and faculititive glucose transporters GLUT1 and GLUT3: Putative molecular components of the oxygen and glucose sensing apparatus in articular chondrocytes. Histol Histopathol 2005;20:1327-38.
84. Morales M, Gonzales-Mejia ME, Bernabe A, Hernandez-Kelly LC, Ortega A. Glutamate activates protein knase B (PKB/Akt) through AMPA receptors in cultured Bergmann glia. Neurochem Res 2006;31:423-9.
85. Noch E, Khalili K. Molecular mechanisms of necrosis in glioblastoma: The role of glutamate excitotoxicity. Cancer Biol Ther 2009;8:1791-7.
86. Oberg HH, Juricke M, Kabelitz D, Wesch D. Regulation of T cell activation by TLR ligands. Eur J Cell Biol 2011;90:582-92.
87. Ohka F, Natsume A, Wakabayashi T. Current ternds in targeted therapies for glioblastoma multiforme. Neurol Res Int 2012;2012:878425.
88. Olney JW, Ho OL. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 1970;227:609-11.
89. Olney JW, Labruyere J, de Gubareff T. Brain damage in mice from voluntary ingestion of glutamate and aspartate. Neurobiol Toxicol 1980;2:125-9.
90. O'Neill LA, Kaltschmidt C. NF-κB: A crucial transcription factor for glial and neuronal cell function. Trends Neurosci 1997;20:252-58.
91. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999;18:6853-66.
92. Patel SA, Warren BA, Rhoderick JF, Bridges RJ. Differentiation of substrate and non-substrate inhibitors of transport system xc(-): And obligate exchanger of L-glutamate and L-cystine. Neuropharmacology 2004;46:273-84.
93. Piao Y, Lu L, de Groot J. AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matric. Neuro Oncol 2009;11:260-73.
94. Pissimissis N, Papageorgiou E, Lembessis P, Armakolas A, Koutsilieris M. The glutamatergic system expression in human PC-3 and LNCaP prostate cancer cells. Anticancer Res 2009;29:371-7.
95. Plant K, Pelkey KA, Bortolotto ZA, Morita D, Terashima A, McBain CJ, et al. Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation. Nat Neurosci 2006;9:602-4.
96. Qiang L, Wu T, Zhang HW, Lu N, Hu R, Wang YJ, et al. HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway. Cell Death Differ 2012;19:284-94.
97. Ravenna L, Sale P, Di Vito M, Russo A, Salvatori L, Tafani M, et al. Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma. Prostate 2009;69:1245-55.
98. Reynes G, Vila V, Martin M, Parada A, Fleitas T, Reganon E, et al. Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. J Neurooncol 2011;102:35-41.
99. Rijpkema M, Schuuring J, van der Meulen Y, van der Graaf M, Bernsen H, Boerman R, et al. Characterization of oligodendrogliomas using short echo time 1 H MR spectroscopic imaging. NMR Biomed 2003;16:12-8.
100. Roslin M, Henricksson R, Bergstrom P, Ungerstedt U, Bergenheim AT. Baseline levels of glucose metabolites, glutamate and glycerol in malignant gliom assessed by sterotatic microdialysis. J Neuro-oncol 2003;61:151-60.
101. Rzeski W, Turski L, Ikonomidou C. Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA 2001;98:6372-7.
102. Sakuma S, Sawamura Y, Tada M, Aida T, Abe H, Suzuki K, et al. Responses of human glioblastoma cells to human natural tumor necrosis factor-Alpha: Susceptibility, mechanics of resistance and cytokine production studies. J Neurooncol 1993;15:197-208.
103. Schwanborn J, Lindecke A. Elvers M, Horojschi V, Kerick M, Rafigh M, et al. Microarray analysis of tumor necrosis factor alpha induced gene expression in U373 human glioblastoma cells. BMC Geonomics 2003;4:46.
104. Seltzer MJ, Bennett BD, Joshi AD, Gao P, Thomas AG, Ferraris DV, et al. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res 2010;70:8981-7.
105. Sen E. Targeting inflammation-induced transcription factor activation: An open frontier for glioma therapy. Drug Discov Today 2011;16:1044-51.
106. Shiba E, Kim S, Fujitani M, Kambayashi I, Tsujimoto S, Shimomura K, et al. Possible involvement of calpain in the growth of estrogen receptor positive breast cancer cells. Anticancer Res 1996;16:773-7.
107. Shnaper S, Desbaillets I, Brown DA, Murat A, Migliavacca E, Schluep M, et al. Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worst outcome. In J Cancer 2009;125:2624-30.
108. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, et al. Macrophage polarization in tumor progression. Semin Cancer Biol 2008;18:349-55.
109. Siveen KS, Kuttan G. Role of macrophages in tumor progression. Immunol Lett 2009;123:97-102.
110. Sontheimer H, Bridges RJ. Sulfasalazine for brain cancer fits. Expert Opin Investig Drugs 2012;21:575-8.
111. Stegink LD, Filer LJ Jr, Baker GL. Plasma amino acid concentrations in normal adults ingesting aspartame and monosodium L-glutamate as part of a soup/beverage meal. Metabolism 1987;36:1073-9.
112. Stellwagen D, Beattie EC, Seo JY, Malenka RC. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-Alpha. J Neurosci 2005;25:3219-28.
113. Stepulak A, Sifringer M, Rzeski W, Endesfelder S, Gratopp A, Pohl EE, et al. NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc Natl Acad Sci USA 2005;102:15605-10.
114. Stepulak A, Luksch H, Gebhardt C, Uckermann O, Marzahn J, Rzeski W, et al. Expression of glutamate receptor subunits in human cancers. Histochem Cell Biol 2009;132:435-45.
115. Tafani M, Russo A, Di Vito M, Sale P, Pellegrini L, Schito L, et al. Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment. Cancer Sci 2010;101:1014-23.
116. Tafani M, Di Vito M, Frati A, Pelligrini L, De Dantis E, Sette G, et al. Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma. J Neuroinflammation 2011;8:32.
117. Takano T, Lin JH, Aruino G, Gao Q, Yang J, Nedergaard M. Glutamate release promotes growth of malignant gliomas. Nat Med 2001;7:1010-5.
118. Takeuchi H Neurotoxicity by microglia: Mechanisms and potential therapeutic strategy. Clin Exp Neuroimmunol 2010;1:12-21.
119. Van Damme P, Bracken D, Callewaert G, Robberecht W, Van Den Bosh L. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2005;64:605-12.
120. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, et al. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and stauroporine. Mol Cell 2000;6:909-19.
121. Wang JB, Erickson JW, Fuji R, Ramachandran S, Gao P, Dinavahi R, et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 2010;18:207-19.
122. Weaver AM. Regulation of cancer invasion by reactive oxygen species and Tks family scaffold proteins. Sci Signal 2009;2:56.
123. Widera D, Holtkamp W, Entschladen F, Niggemann B, Zanker K, Kaltschmidt B, et al. MCP-1 induces migration of adult stem cells. Eur Cell Biol 2004;83:381-7.
124. Widera D, Mikenberg I, Elvers M, Kaltschmidt C, Kaltschmidt B. Tumor necrosis factor α triggers proliferation of adult neural stem cells via IKK/KF-kB signaling. BMC Neurosci 2006;7:64.
125. Wu A, Wei J, Kong LK, Wang Y, Priebe W, Oiao W, et al. Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol 2010;12:1113-25.
126. Ye ZC, Sontheimer H. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 1999;59:4383-91.
127. Ye ZC, Rothstein JD, Sontheimer H. Compromised glutamate transport in human glioma cells: Reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J Neurosci 1999;19:10767-77.
128. Yudowski GA, Puthenveedu MA, Leonoudakis D, Panicker S, Thorn KS, Beattie EC, et al. Real-time imaging of discrete exocytic events mediating surface delivery of AMPA receptors. J Neurosci 2007;27:11112-21.
129. Zaveri NT. Green tea and its polyphenol catechins: Medicinal uses in cancer and noncancer applications. Life Sci 2006;78:2073-80.
130. Zujovic V, Benavides J, Vige X, Carter C, Taupin V. Fractalkine modulate TNF-Alpha secretion and neurotoxicity induced by microglial activation. Glia 2000;29:305-15.